On the optimal dosage of Pro-Leu-Gly-NH2 (MIF) in neuropharmacological tests and clinical use

No abstract is available for this paper.

• Publication year

  1977

• Venue

  Naunyn-Schmiedeberg's Archives of Pharmacology

• Publication date

  1977-06-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/BF00508614PMID 18686
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neuropharmacology of hypothalamic releasing factors

  1976cited by this paper
• Commentary: Neuropharmacology of hypothalamic releasing factors.

  1976cited by this paper
• Peptides related to melanostatin (Pro-Leu-Gly-NH2) as inhibitors of oxotremorine-induced tremor.

  1976cited by this paper
• Double-blind evaluation of oral L-prolyl-Lleucyl-glycine amide in Parkinson's disease.

  1976cited by this paper
• [Infusion therapy with mif (melanocyte inhibiting factor) in Parkinson's disease (author's transl)].

  1975cited by this paper
• Intensification of central catecholaminergin and serotonergic processes by the hypothalamic factors MIF and TRF and by angiotensin II.

  1975cited by this paper
• α-MSH and MIF-I effects on catecholamine levels and synthesis in various rat brain areas☆

  1975cited by this paper
• Studies on the inhibition of oxotremorine induced tremor by a melanocyte‐stimulating hormone release‐inhibiting factor, thyrotropin releasing hormone and related peptides

  1974cited by this paper
• Oxotremorine antagonism by prolyl-leucyl-glycine-amide administered by different routes and with several anticholinergics.

  1974cited by this paper
• DOPA potentiation in ablated animals and brain levels of biogenic amines in intact animals after prolyl-leucylglycinamide.

  1974cited by this paper
• Effect of melanocyte-stimulating hormone-release inhibiting factor (MIF) in Parkinson's syndrom.

  1974cited by this paper
• Dopamine Synthesis: Stimulation by a Hypothalamic Factor

  1973cited by this paper
• Deserpidine antagonism by a tripeptide, L-prolyl-L-leucyglycinamide.

  1973cited by this paper
• Preliminary clinical studies with L-prolyl-L-leucyl-glycine amide in Parkinson's disease.

  1972cited by this paper
• Oxotremorine Antagonism by a Hypothalamic Hormone, Melanocyte-Stimulating Hormone Release-Inhibiting Factor (MIF)

  1972cited by this paper
• DOPA potentiation by a hypothalamic factor, MSH release-inhibiting hormone (MIF).

  1971cited by this paper
• Tremor analyzer for small laboratory animals

  1970cited by this paper
• The Up-and-Down Method for Small Samples

  1965cited by this paper

• Stapling Amantadine to Melanostatin Neuropeptide: Discovery of Potent Positive Allosteric Modulators of the D2 Receptors.

  2023cites this paper
• Lambda Red-Mediated Recombination in Shiga Toxin-Producing Escherichia coli.

  2021cites this paper
• Allosteric modulation of dopamine receptors.

  2005cites this paper
• Modulatory effects of PLG and its peptidomimetics on haloperidol-induced catalepsy in rats.

  1999cites this paper
• Prevention and reversal of dopamine receptor supersensitivity by cyclo(leucyl-glycyl) (CLG): biphasic dose-response curves.

  1994cites this paper
• Interaction of l‐Prolyl‐l‐Leucyl Glycinamide with Dopamine D2 Receptor: Evidence for Modulation of Agonist Affinity States in Bovine Striatal Membranes

  1988cites this paper
• Down-regulation of haloperidol-induced striatal dopamine receptor supersensitivity by active analogues of L-prolyl-L-leucyl-glycinamide (PLG).

  1987cites this paper
• Pharmacological activities of the MIF-1 analogues Pro-Leu-Gly, Tyr-Pro-Leu-Gly and pareptide.

  1987cites this paper
• Effects of Pro-Leu-Gly-NH2 and cyclo (Leu-Gly) on the binding of 3H-quinuclidinyl benzilate to striatal cholinergic muscarinic receptors.

  1986cites this paper
• Radio-frequency analysis of the effect of haloperidol and cyclo (leucyl-glycyl) on apomorphine-induced stereotypy.

  1986cites this paper
• Synthesis of Pro-Leu-Gly-NH2 analogues modified at the prolyl residue and evaluation of their effects on the receptor binding activity of the central dopamine receptor agonist, ADTN.

  1986cites this paper
• CNS Dopamine Receptors: Effect of Prolyl-Leucyl-Glycinamide and Solubilization

  1984cites this paper
• The effect of thyrotropin releasing hormone and morphine on gastrointestinal transit.

  1984cites this paper
• Pro-Leu-Gly-NH2 and pareptide inhibit development of tolerance to haloperidol catalepsy in the mouse.

  1984cites this paper
• Actions of substance P, MIF, TRH and related peptides in the substantia nigra, caudate nucleus and nucleus accumbens.

  1983cites this paper
• Pharmacology of L-prolyl-L-leucyl-glycinamide (PLG): a review.

  1983cites this paper
• The effect of melanotropin release inhibiting factor, its metabolites and analogs on [3H]spiroperidol and [3H]apomorphine binding sites.

  1983cites this paper
• Effect of Tyr-Pro-Leu-Gly-NH2 on melanotropin-stimulating hormone release in the frog and rat.

  1983cites this paper
• Neurohypophyseal hormones and brain neurochemistry.

  1982cites this paper
• Effects of naltrexone and prolyl-leucyl-glycinamide on drug-induced tremor and rigidity in the rat.

  1981cites this paper
• Effect of L-prolyl-L-leucyl-glycinamide (PLG) on neuroleptic-induced catalepsy and dopamine/neuroleptic receptor bindings.

  1981cites this paper
• MIF (Pro‐Leu‐Gly‐NH2): failure to affect oxotremorine effects in mice and rats as well as fluphenazine catalepsy or amphetamine hyperactivity in rats

  1980cites this paper
• Unusual dose-related effect of an endorphin analog in a complex maze.

  1980cites this paper
• Tripeptide analogues of melanocyte-stimulating hormone release-inhibiting hormone (Pro-Leu-Gly-NH2) as inhibitors of oxotremorine-induced tremor.

  1979cites this paper
• CNS effects of peripherally administered brain peptides.

  1979cites this paper
• Peripheral administration of hypothalamic peptides results in CNS changes.

  1978cites this paper
• Behavioural effects of naloxone in rats

  1978cites this paper
• An allenic oxotremorine analogue.

  1978cites this paper